Alison Marie Barnard1, Donovan Lott1, Abhinandan Batra1, William Triplett1, Sean Forbes1, Samuel Riehl1, Rebecca Willcocks1, Barbara Smith1, Krista Vandenborne1, and Glenn Walter2
1Department of Physical Therapy, University of Florida, Gainesville, FL, United States, 2Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, United States
Synopsis
In
Duchenne muscular dystrophy (DMD), respiratory muscle weakness leads to
eventual respiratory failure. For this
investigation, dynamic MRI was utilized to characterize diaphragm and chest
wall dynamics during breathing, and chemical shift-encoded imaging was utilized
to assess fatty infiltration in accessory respiratory muscles in 36 individuals
with DMD and 12 unaffected controls. For
maximal inspirations, individuals with DMD had significantly reduced
anterior-posterior chest expansion, and a subgroup with poor respiratory
function had decreased diaphragm descent (normalized to height). The expiratory muscles had high levels of
fatty infiltration, and muscle fat fraction was correlated with measures of
expiratory muscle strength.
Introduction
Duchenne
muscular dystrophy (DMD) is a progressive muscle degenerative disease
characterized by damage, inflammation, and necrosis of muscle fibers with ultimate
replacement by fibrofatty connective tissue.1 Dystrophic muscles become weak resulting in
impaired mobility, cardiac dysfunction, and respiratory dysfunction, and respiratory
impairment is a major cause of morbidity and mortality in DMD. A decrease in expiratory function is often the
first sign of respiratory impairment, reflected by a decrease in maximal
expiratory pressure (MEP), a measure of expiratory muscle strength.2 This is followed by decreases in both forced
vital capacity (FVC), a global measure of pulmonary function, and maximal
inspiratory pressure (MIP), a measure of inspiratory muscle strength.2,3 Continued decline leads to eventual
respiratory failure. MRI offers a unique
method to assess respiratory muscle health and function in vivo in DMD, yet
there has been only preliminary work examining diaphragm and chest wall motion
using MR methods.4,5
Therefore, the aim of this project was to investigate the pattern of respiratory muscle
involvement and chest wall dynamics in DMD using quantitative MR methods.Methods
36
participants with DMD (ages 7-18 years old) and 12 unaffected controls (ages
6-18 years old) underwent an MRI exam of
the thorax and abdomen using a 3T Phillips Achieva MRI and 32-channel chest
coil. Dynamic MRI (~5-7
frames/sec) was used to obtain sagittal slices through the right lung during
free breathing, maximal inspirations, and maximal expirations. Diaphragm and
chest wall movement was quantified during breathing. Additionally, chemical shift-encoded
(CSE) imaging was performed to examine accessory respiratory muscle fatty
infiltration. We acquired coronal chest, axial chest, and axial
abdominal images using a single-slice, free breathing protocol with SENSE
acceleration for chest images. Parameters were as follows: TR= 10ms (gated),
TE= 5.4, 6.4, 7.4ms, flip angle= 3o and 10o, slice
thickness= 6mm, resolution= 0.6 X 0.6mm2, NSA=6. Images were reconstructed using a seven peak
precalibrated lipid model to produce fat and water images. Fat fraction (FF)
was determined for the accessory respiratory muscles of expiration (external
oblique, internal oblique, and rectus abdominis) using the formula FF = (fat
signal) / (fat+water signal). After MRI
acquisition, participants completed clinical tests of pulmonary function
including forced vital capacity (FVC), maximal inspiratory pressure (MIP), and
maximal expiratory pressure (MEP) measures.Results
Participants
with DMD had impaired FVC, MIP, and MEP values compared to controls (p<0.001
for all tests). Dynamic imaging revealed
that individuals with DMD had smaller increases in sagittal plane lung area
during maximal inspirations (p=0.003; FIG 1) and smaller decreases in lung area
during maximal expirations (p<0.001; FIG 2).
Additionally, diaphragm descent was decreased during maximal
inspirations, but when descent was normalized to height, only individuals with
MIPs≤60% predicted had impaired diaphragm descent
(FIG 1B). Chest movement in the
anterior-posterior direction was reduced during maximal breathing in DMD
compared to controls. CSE MRI revealed
significantly elevated expiratory respiratory muscle FF compared to controls
with mean FF=0.32 (p<0.001) in the rectus abdominis; FF=0.41 (p<0.001) in
the external oblique, and FF=0.49 (p<0.001) in the internal oblique (FIG 3
and FIG 4). MEP was negatively correlated to the FF of the internal oblique
muscle (r=-0.70, p<0.001). Visual inspection of the CSE MRI of the chest
revealed that the intercostal muscles tended to have minimal fatty infiltration
in individuals with DMD, even in individuals with nearly complete fatty
replacement of other muscles of the chest (FIG 5).Conclusions
Dynamic
MRI and CSE MRI were able to capture novel findings regarding respiratory
impairment and respiratory muscle involvement in DMD. Overt MRI signs of diaphragm dysfunction were
not present in DMD until inspiratory muscle strength (MIP) was significantly
impaired; however, chest mobility during maximal breathing was reduced even in
some individuals with normal pulmonary function tests. Failed regeneration of
skeletal muscle in DMD leads to significant fatty infiltration of the chest and
expiratory muscles yet a relative sparing of the intercostal muscles, and high
amounts of fatty infiltration of the expiratory respiratory muscles are
reflected functionally as reduced expiratory muscle strength. These findings
contribute to a better characterization of respiratory muscle involvement in
DMD, and future development of these MR measures as biomarkers may be useful to
help determine intervention efficacy.Acknowledgements
Thank you to the participants and their families for their participation in this study, and thank you to the MR technologists for their assistance with data collection. Funding included support from: Failed Regeneration in the Muscular
Dystrophies: Inflammation, Fibrosis, and Fat (NIAMS: U54R05264601);
Magnetic Resonance Imaging and
Biomarkers in Muscular Dystrophy (NIAMS: R01 AR056973); and
Interdisciplinary Training in
Rehabilitation and Neuromuscular Plasticity (NICHD: T32 HD043730).
References
1. Peverelli L,
Testolin S, Villa L, et al. Histologic muscular history in steroid-treated and
untreated patients with Duchenne dystrophy. Neurology. 2015;85(21):1886–1893.
2. Hahn
A, Bach JR, Delaubier A, et al. Clinical implications of maximal respiratory
pressure determinations for individuals with Duchenne muscular dystrophy. Arch.
Phys. Med. Rehabil. 1997;78(1):1–6.
3. LoMauro
A, Romei M, Gandossini S, et al. Evolution of respiratory function in Duchenne
muscular dystrophy from childhood to adulthood. Eur. Respir. J. 2018;51(2):1701418.
4. Bishop
CA, Ricotti V, Sinclair CDJ, et al. Semi-automated analysis of diaphragmatic
motion with dynamic magnetic resonance imaging in healthy controls and
non-ambulant subjects with Duchenne muscular dystrophy. Front. Neurol.
2018;9(9).
5. Mankodi
A, Kovacs W, Norato G, et al. Respiratory magnetic resonance imaging biomarkers
in Duchenne muscular dystrophy. Ann. Clin. Transl. Neurol. 2017;4(9):655–662.